We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Ultra Fast Synovial Fluid Test Diagnoses Osteoarthritis and Rheumatoid Arthritis In 10 Minutes

By LabMedica International staff writers
Posted on 05 May 2025

Studies indicate that more than 50% of individuals aged 65 and older experience symptoms of osteoarthritis, while rheumatoid arthritis is a serious chronic condition affecting approximately 1 in 100 people during their lifetime. More...

Although osteoarthritis and rheumatoid arthritis may appear similar, they have distinct causes and require different treatments, making accurate early diagnosis crucial. Traditionally, diagnosis has relied on X-rays, MRI scans, and blood tests, all of which are time-consuming, expensive, and not always accurate. Now, a new technology enables the diagnosis of osteoarthritis and rheumatoid arthritis within 10 minutes using synovial fluid produced in human joints.

A research team at the Korea Institute of Materials Science (KIMS, Gyeongsangnam-do, Korea) and their collaborators focused on differences in the composition of metabolites—byproducts of chemical processes within the body—found in synovial fluid. By analyzing these metabolic variations, the team developed a technology capable of distinguishing between osteoarthritis and rheumatoid arthritis in just 10 minutes, while also evaluating the severity of rheumatoid arthritis. The researchers employed Surface-Enhanced Raman Scattering (SERS) technology, which amplifies the optical signals of molecules by several million times. This technique enhances the signals of trace molecules in synovial fluid, and, combined with AI-driven analysis and mathematical algorithms, it can detect tiny substances responsible for arthritis.

Additionally, the team designed a rapid and simple diagnostic method using a sensor made from a sea urchin-shaped gold nanostructure on a paper surface that has high moisture absorption, allowing for efficient detection through body fluids. In collaboration with their research partners, the team conducted tests with this technology on 120 patients. The results, published in the journal Small, demonstrated that the technology could diagnose and differentiate osteoarthritis from rheumatoid arthritis with over 94% accuracy. Moreover, it achieved more than 95% accuracy in determining the severity of rheumatoid arthritis. These findings show that this technology not only significantly reduces the time and cost of diagnosing arthritis but also ensures a high degree of diagnostic precision.

“If this technology is commercialized, it will not only aid in diagnosis but also be highly useful in monitoring treatment progress,” said Dr. Ho Sang Jung, the lead researcher at KIMS. “We also plan to continue expanding our research to cover a wider range of diseases in the future.”


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Blood Gas and Chemistry Analysis System
Edan i500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.